NEW YORK (GenomeWeb) – Editas Medicine has announced a three-year collaboration with Italy's Fondazione Telethon and Ospedale San Raffaele to research and develop gene-edited hematopoietic stem cell and T-cell therapies.

Under the terms of the agreement, Editas will collaborate with the Milan-based San Raffaele Telethon Institute for Gene Therapy, a joint project of the two Italian partners. The collaborators will try to develop gene-editing approaches to treat rare diseases, including unspecified indications in blood and bone marrow.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.